Insulet PODD
NASDAQ PODD
$134.96 -2.96 (-2.14%)
As of: Sep 10, 2026 · 2:51 PM EDT

Insulet (PODD) Cash from Operations (2010 - 2026)

Insulet's (PODD) quarterly Cash from Operations came in at $88.4 million in Q2 2026, down 55.01% on a YoY basis from $196.5 million in Q2 2025, and down 22.32% quarter-over-quarter from $113.8 million in Q1 2026.

Analysis

Insulet (PODD) Cash from Operations (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Cash from Operations for 17 consecutive years, with $88.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Operations fell 55.01% year-over-year to $88.4 million; the trailing twelve-month figure through Jun 2026 stood at $511.2 million (down 0.95% YoY), and the FY2025 full-year result was $569.3 million, up 32.33% from the prior year.
  • Cash from Operations fell to $88.4 million in Q2 2026 per PODD's latest filing, from $113.8 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $196.5 million in Q2 2025 and bottomed at -$13.7 million in Q1 2022.
  • Historically, Cash from Operations has averaged $81.5 million across 5 years, with a median of $75.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Cash from Operations jumped 17420.0% in 2024, then plunged 55.01% in 2026.
  • Over 5 years, Cash from Operations stood at $50.7 million in 2022, then fell by 10.85% to $45.2 million in 2023, then surged by 226.33% to $147.5 million in 2024, then climbed by 24.27% to $183.3 million in 2025, then plunged by 51.77% to $88.4 million in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered $88.4 million, $113.8 million, and $183.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 180.55 Bn 174.95 Bn 7.27 Bn 2.49 Bn
2 Intuitive Surgical 127.52 Bn 122.30 Bn 1.96 Bn 1.06 Bn
3 Medtronic 117.07 Bn 108.26 Bn 6.34 Bn 1.79 Bn
4 Stryker 103.72 Bn 100.25 Bn 4.50 Bn 1.26 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 49.71 Bn 45.45 Bn 1.35 Bn 651.90 Mn
7 Alcon 33.00 Bn 31.55 Bn 1.68 Bn 510.00 Mn
8 Dexcom 32.13 Bn 30.18 Bn 830.00 Mn 269.20 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 367.10 Mn
10 Insulet 9.31 Bn 8.77 Bn 562.60 Mn 88.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88.40 Mn
Mar 31, 2026 113.80 Mn
Dec 31, 2025 183.30 Mn
Sep 30, 2025 125.70 Mn
Jun 30, 2025 196.50 Mn
Mar 31, 2025 63.80 Mn
Dec 31, 2024 147.50 Mn
Sep 30, 2024 108.30 Mn
Jun 30, 2024 86.80 Mn
Mar 31, 2024 87.60 Mn
Dec 31, 2023 45.20 Mn
Sep 30, 2023 56.00 Mn
Jun 30, 2023 44.00 Mn
Mar 31, 2023 500,000.00
Dec 31, 2022 50.70 Mn
Sep 30, 2022 56.70 Mn
Jun 30, 2022 25.30 Mn
Mar 31, 2022 -13.70 Mn
Dec 31, 2021 -25.50 Mn
Sep 30, 2021 -25.80 Mn